Related Experiment Video
Updated: Feb 5, 2026

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
Published on: February 21, 2014
Phosphodiesterase 7B/microRNA-200c relationship regulates triple-negative breast cancer cell growth
Dan-Dan Zhang1, Yue Li2, Yuan Xu3
1Institute of Interdisciplinary Integrative Medical Research, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China. izhangdd@126.com.
Abstract:
Members of microRNA-200 (miRNA-200) family have a regulatory role in epithelial to mesenchymal transition (EMT) by suppressing Zeb1 and Zeb2 expression. Consistent with its role in suppressing EMT, Hsa-miR-200c-3p (miR-200c), a member of miR-200 family is poorly expressed in mesenchymal-like triple-negative breast cancer (TNBC) cells and ectopic miR-200c expression suppresses cell migration. In this study, we demonstrated that miR-200c potently inhibited TNBC cell growth and tumor development in a mechanism distinct from its ability to downregulate Zeb1 and Zeb2 expression, because silencing them only marginally affected TNBC cell growth. We identified phosphodiesterase 7B (PDE7B) as a bona fide miR-200c target. Importantly, miR-200c-led inhibition in cell growth and tumor development was prevented by forcing PDE7B transgene expression, while knockdown of PDE7B effectively inhibited cell growth. These results suggest that miR-200c inhibits cell growth by targeting PDE7B mRNA. To elucidate mechanism underlying miR-200c/PDE7B regulation of TNBC cell growth, we showed that cAMP concentration was lower in TNBC cells compared with estrogen receptor-positive (ER + ) cells, and that both miR-200c and PDE7B siRNAs were able to increase cAMP concentration in TNBC cells. High level of cellular cAMP has been shown to induce cell cycle arrest and apoptosis in TNBC cells. Our observation that ectopic expression of miR-200c triggered apoptosis indicates that it does so by elevating level of cellular cAMP. Analysis of breast tumor gene expression datasets revealed an inverse association between miR-200c and PDE7B expression. Especially, both low miR-200c and high PDE7B expression were correlated with poor survival of breast cancer patients. Our study supports a critical role of miR-200c/PDE7B relationship in TNBC tumorigenesis.
Insights
MicroRNA-200c (miR-200c) inhibits triple-negative breast cancer (TNBC) growth by targeting phosphodiesterase 7B (PDE7B), distinct from its known EMT role. This interaction elevates cAMP levels, promoting apoptosis and potentially improving patient survival.
Area of Science:
- Molecular Biology
- Cancer Research
- Genetics
Background:
- MicroRNA-200 (miRNA-200) family members regulate epithelial-to-mesenchymal transition (EMT) by suppressing Zeb1 and Zeb2.
- Hsa-miR-200c-3p (miR-200c), a member of the miRNA-200 family, is underexpressed in triple-negative breast cancer (TNBC) and inhibits cell migration.
- The precise mechanism of miR-200c's role in TNBC growth inhibition beyond EMT suppression requires elucidation.
Purpose of the Study:
- To investigate the mechanism by which miR-200c inhibits TNBC cell growth and tumor development.
- To identify novel targets of miR-200c involved in TNBC pathogenesis.
- To explore the therapeutic potential of the miR-200c/target interaction in TNBC.
Main Methods:
- Utilized cell culture models of TNBC and ectopic miR-200c expression.
- Performed gene silencing (siRNA) and overexpression (transgene) experiments for miR-200c and its targets.
- Quantified intracellular cAMP levels and assessed apoptosis and cell cycle arrest.
- Analyzed patient tumor gene expression datasets for correlation analysis.
Main Results:
- miR-200c potently inhibited TNBC cell growth and tumor development through a mechanism independent of Zeb1/Zeb2 downregulation.
- Phosphodiesterase 7B (PDE7B) was identified as a direct target of miR-200c, mediating its tumor-suppressive effects.
- miR-200c increased intracellular cAMP levels in TNBC cells, leading to apoptosis and cell cycle arrest.
- Low miR-200c and high PDE7B expression correlated with poor patient survival in breast cancer datasets.
Conclusions:
- miR-200c inhibits TNBC cell growth and tumor development by targeting PDE7B mRNA, leading to elevated cAMP levels and apoptosis.
- The miR-200c/PDE7B axis represents a novel regulatory pathway in TNBC tumorigenesis.
- This pathway holds potential as a therapeutic target for improving outcomes in breast cancer patients, particularly those with TNBC.
Related Concept Videos
Negative Regulator Molecules
MicroRNAs
MicroRNAs
Relationship Growth
Relationship Formation
pH Regulation in Cells
Cytosolic pH
Under physiological conditions, the cytosolic pH is slightly more acidic than the extracellular pH. However, cells must prevent further acidification of their cytosol to...

